E Thehiloe ka 2009, JYMed ke mofani oa litšebeletso tse ka sehloohong tsa peptide CRDMO le moetsi oa API ea generic naheng ea China e sebetsanang le tloaelo ea ho kopanya, nts'etsopele ea ts'ebetso, phepelo ea bongaka le thekiso ea lintho tsa peptide. Khamphani e sebelisa li-FTEs tse ka bang 600+, tse nang le sehlopha sa batsamaisi ba mantlha se entsoeng ka litsebi tse nang le boiphihlelo ba lilemo tse fetang 20 tsa theknoloji ea peptide. JYMed e sebetsa setsi se le seng sa R&D le lits'ebeletso tse peli tse kholo tsa tlhahiso ea merero e mengata, tse nang le matla a tlhahiso ea lithane tse ngata tsa peptide.
Joalo ka k'hamphani e shebaneng le bareki, JYMed e fana ka sethala se felletseng sa nts'etsopele ea peptide le ts'ebetso ea indasteri e tšehelitsoeng ke lilemo tse fetang 20 tsa boiphihlelo ba R&D le lits'ebeletso tsa morao-rao. Re fana ka li-peptide tsa boleng bo holimo tse etselitsoeng litlhoko tsa moreki e mong le e mong.
JYMed e fana ka potefolio e pharaletseng ea li-API tsa peptide tse fetang 20, ho kenyelletsa Semaglutide, Tirzepatide, Liraglutide, Degarelix, le Oxytocin. Tse 'maloa tsa tsona, tse kang Semaglutide le Tirzepatide, li atlehile ho qeta ho ngolisa le ho etsa khoebo.
JYMed e fana ka sethala sa CDMO se felletseng le se sebetsang hantle, se fana ka lits'ebeletso tse felletseng bakeng sa lihlahisoa tsa peptide le analoge ea peptide. Sena se kenyelletsa lipatlisiso le tlhahiso ea li-peptide tsa kalafo, li-peptide tsa bongaka ba liphoofolo, le tse ling.
JYMed e fana ka li-peptide tsa cosmetic tsa boleng bo holimo, lisebelisoa tse tala, le liforomo tsa OEM ho tloha lipatlisisong ho isa sehlopheng sa cGMP — kaofela li tlas'a taolo e thata ea boleng. Li-peptide tsa rona tsa maiketsetso li ratoa haholo bakeng sa polokeho ea tsona, bohloeki le boiketlo ba tsona.
JYMed ke moetsi oa lipeptide o hlahlobiloeng ke FDA oa US ea sebetsanang le li-peptide tsa litlolo, li-API tsa li-peptide le li-peptide tsa tloaelo. Lihlahisoa tsa rona tse hlahang li kenyelletsa Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-Cu, Acetyl Hexapeptide-8, le ho feta. Ho ithuta haholoanyane, ka kopo ikopanye le rona ho:
Email: jymed@jymedtech.com
CPHI China 2025 e tla etsahala ho tloha ka June 24-26, 2025, Setsing sa Shanghai New International Expo Centre (SNIEC). E nka sebaka sa lisekoere-mithara tse fetang 230,000, ketsahalo e reretsoe ho amohela ba bonts'ang ba fetang 3,500 le ho hohela litsebi tsa indasteri tse fetang 100,000. E le e 'ngoe ea linaha tse kholo ka ho fetisisa tsa Asia le tse nang le tšusumetso e kholo ...
Hubei JXBio Pharmaceutical Co., Ltd., sebaka sa tlhahiso ea peptide se inehetseng sa JYMed, se phethetse ka katleho tlhahlobo e 'ngoe ea sebakeng seo ke US Food and Drug Administration (FDA) ho tloha ka la 10-14 Hlakubele. Tlhatlhobo eo, e leng karolo ea tlhahlobo ea Tiisetso ea Boleng ba Lithethefatsi, e hlahlobile litsamaiso tsa bohlokoa tse kenyeletsang boleng, tlhahiso...
JYMed e kentse tšebetsong tsamaiso e matla ea tsamaiso ea boleng, e fumane mangolo a mararo bakeng sa ho fana ka lihlahisoa le lits'ebeletso kamehla tse fihlelang maemo a lefats'e.Katleho ea setifikeiti sa ISO 9001 e bonts'a hore khamphani e na le lits'ebetso le litekanyetso tse hlalositsoeng hantle bakeng sa taolo ea kahare...